Chemical modification of tumour blood flow

References

• Burtin C., Scheinmann P., Salomon J. C., Lespinats G., Canu P. Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma-bearing mice: influence of H1 and H2 histamine receptors. British Journal of Cancer 1982; 45: 54–60
   PubMed Web of Science ®Google Scholar
• Calderwood S. K., Dickson J. A. Inhibition of tumor blood flow at high blood sugar levels: effects on tumor pH and hyperthermia. National Cancer Institute Monograph 1982; 61: 221–223
   Google Scholar
• Cater D. B., Grigson C. M.B., Watkinson D. A. Changes of oxygen tension in tumors induced by vasoconstriction and vasodilator drugs. Acta Radiologica 1962; 58: 401–436
   PubMed Web of Science ®Google Scholar
• Cater D. B., Schoeniger E. L., Watkinson D. A. Effect of breathing high pressure oxygen upon tissue oxygen tension in rat and mouse tumours. Acta Radiologica Therapy, Physics, Biology 1963; 1: 233–252
   PubMed Web of Science ®Google Scholar
• Chaplin D. J., Olive P. L., Durand R. E. Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Research 1987; 47: 597–601
   PubMed Web of Science ®Google Scholar
• Crile G., Jr. The effects of heat and radiation on cancers implanted on the feet of mice. Cancer Research 1963; 23: 372–380
   PubMed Web of Science ®Google Scholar
• Daugherty R. M., Scott J. B., Emerson T. E., Haddy F. J. Comparison of iv and ia infusion of vasoactive agents. American Journal of Physiology 1968; 214: 611–619
   PubMedGoogle Scholar
• Eden M., Haines B., Kahler H. The pH of rat tumors measured in vivo. Journal of the National Cancer Institute 1955; 16: 541–556
   PubMedGoogle Scholar
• Ekelund L. Angiography and pharmacoangiography in human and experimental tumors. Tumor Blood Circulation: angiogenesis, vascular morphology and blood flow of experimental and human tumors, H-I. Peterson. CRC Press, Boca Raton, FL 1979; 185–202, chapter 11
   Google Scholar
• Emerson T. E., Meier P. D., Daugherty R. M. Dependence of skeletal muscle vascular response to serotonin upon the level of vascular resistance. Proceedings of the Society for Experimental Biology and Medicine 1973; 142: 1185–1188
   PubMedGoogle Scholar
• Endrich B., Reinhold H. S., Gross J. F., Intaglietta M. Tissue perfusion inhomogeneity during early tumor growth in rats. Journal of the National Cancer Institute 1979; 62: 387–395
   PubMed Web of Science ®Google Scholar
• Endrich B., Hammersen F., Gotz A., Messmer K. Microcirculatory blood flow, capillary morphology, and local oxygen pressure of the hamster amelanotic melanoma. Journal of the National Cancer Institute 1982; 68: 475–485
   PubMedGoogle Scholar
• Fleckenstein A., Tritthart H., Flackenstein B., Herbst A., Grun G. A new group of competitive divalent Ca-antagonist (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium. Pflugers Archivfiir die Gesamte Physiologie des Menschen und der Tiere 1969; 307: R25
   Google Scholar
• Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G. H. A. Clowes Memorial Award Lecture. Cancer Research 1986; 46: 467–473
   PubMed Web of Science ®Google Scholar
• Gerweck L. E. Modification of cell lethality at elevated temperatures: the pH effect. Radiation Research 1977; 70: 224–235
   PubMed Web of Science ®Google Scholar
• Godfraind T., Kaba A. Blockade or reversal of the contraction induced by calcium and adrenalin in depolarized arterial smooth muscle. British Journal of Pharmacology 1969; 36: 549–560
   PubMed Web of Science ®Google Scholar
• Grega G. J., Adamski S. W. Patterns of constriction produced by vasoactive agents. Federation Proceedings 1987; 46: 270–280
   PubMedGoogle Scholar
• Gullino P. M., Grantham F. H. Studies on the exchange of fluids between host and tumor. II. The blood flow of hepatoma and other tumors in rats and mice. Journal of the National Cancer Institute 1961; 27: 1465–1491
   PubMed Web of Science ®Google Scholar
• Gullino P. M., Clark S. H., Grantham F. H. The interstitial fluid of solid tumors. Cancer Research 1964; 24: 780–788
   PubMed Web of Science ®Google Scholar
• Hill R. P., Stirling D. Oxygen and tumor response. The Eighth International Congress of Radiation Research, E. M. Fielden, J. F. Fowler, J. H. Hendry, D. Scott. Taylor & Francis, London 1987; Volume 2: 725–730
   Google Scholar
• Jain R. K., Ward-Hartley K. Tumor blood flow–characterization, modifications, and role in hyperthermia. IEEE Transactions on Sonics and Ultrasonics 1984; SU-31: 504–526
   Google Scholar
• Jain R. K., Shah S. A., Finney P. L. Continuous noninvasive monitoring of pH and temperature in rat walker 256 carcinoma during normoglycemia and hyperglycemia. Journal of the National Cancer Institute 1984; 73: 429–436
   PubMedGoogle Scholar
• Jirtle R. L. Blood flow to lymphatic metastases in conscious rats. European Journal of Cancer 1981; 17: 53–60
   Google Scholar
• Jirtle R. L., Clifton K. H. The effect of tumor size and host anaemia on tumor cell survival after irradiation. International Journal of Radiation Oncology, Biology and Physics 1978; 4: 395–400
   PubMed Web of Science ®Google Scholar
• Jirtle R. L., Clifton K. H., Rankin J. H.G. Effects of several vasoactive drugs on the vascular resistance of MT-W9B tumors in W/Fu rats. Cancer Research 1978; 38: 2385–2390
   PubMed Web of Science ®Google Scholar
• Kaelin W. G., Shrivastav S., Shand D. G., Jirtle R. L. Effect of verapamil on malignant tissue blood flow in SMT-2A tumor-bearing rats. Cancer Research 1982; 42: 3944–3949
   PubMed Web of Science ®Google Scholar
• Kaelin W. G., Shrivastav S., Jirtle R. L. Blood flow to primary tumors and lymph node metastases in SMT-2A tumor-bearing rats following intravenous flunarizine. Cancer Research 1984; 44: 896–899
   PubMed Web of Science ®Google Scholar
• Knapp W. H., Debatin J., Layer K., Helus F., Altmann A., Sinn H. J., Ostertag H. Selective drug-induced reduction of blood flow in tumor transplants. International Journal of Radiation Oncology, Biology and Physics 1985; 11: 1357–1366
   PubMed Web of Science ®Google Scholar
• La Celle P. L., Weed R. I. The contribution of normal and pathologic erythrocytes to blood rheology. Progress in Hematology 1971; 7: 1–31
   PubMedGoogle Scholar
• Lugnier C., Follenius A., Gerard D., Stoclet J. C. Bepridil and flunarizine as calmodulin inhibitors. European Journal of Pharmacology 1984; 98: 157–158
   PubMedGoogle Scholar
• Majno G., Shea S. M., Leventhal M. S. Endothelial contraction induced by histamine type mediators. Journal of Cellular Biology 1969; 42: 647–672
   PubMed Web of Science ®Google Scholar
• Olive P. L., Chaplin D. J., Durand R. E. Pharmacokinetics binding and distribution of Hoechst 33342 in spheroids and murine tumors. British Journal of Cancer 1985; 52: 739–746
   PubMedGoogle Scholar
• Samulski T. V., Fessenden P., Valdagni R., Kapp D. S. Correlations of thermal washout rate, steady state temperatures, and tissue type in deep seated recurrent or metastatic tumors. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 83–94
   PubMed Web of Science ®Google Scholar
• Sasaki Y., Imaoka S., Hasegawa Y., Nakano S., Ishikawa O., Ohigashi H., Taniguchi K., Koyama H., Iwanaga T., Terasawa T. Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer 1985; 55: 311–316
   PubMed Web of Science ®Google Scholar
• Shrivastav S., Joines W. T., Jirtle R. L. Effect of 5-hydroxytryptamine on tissue blood flow and microwave heating of rat tumors. Cancer Research 1985; 45: 3203–3208
   PubMedGoogle Scholar
• Spedding M. Calcium antagonist subgroups. Trends in Pharmacological Sciences 1985; 6: 109–114
   Google Scholar
• Sutherland R. M, Franko A. J. On the nature of the radiobiologically hypoxic fraction in tumors. International Journal of Radiation Oncology, Biology and Physics 1980; 6: 117–120
   PubMed Web of Science ®Google Scholar
• Suzuki M., Hori K., Abe I., Saito S., Sato H. A new approach to cancer chemotherapy: Selective enhancement of tumor blood flow with angiotensin-II. Journal of the National Cancer Institute 1981; 67: 663–669
   PubMed Web of Science ®Google Scholar
• Thistlethwaite A. J., Alexander G. A., Moylan D. J., III, Leeper D. B. Modification of human tumor pH by elevation of blood glucose. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 603–610
   PubMed Web of Science ®Google Scholar
• Vaupel P. Hypoxia in neoplastic tissue. Microvascular Research 1977; 13: 399–408
   PubMed Web of Science ®Google Scholar
• Vaupel P., Menke H. Blood flow, vascular resistance and oxygen availability in malignant tumors upon intravenous flunarizine. Advances in Experimental Medicine and Biology 1987; 215: 393–398
   PubMedGoogle Scholar
• Voorhees W. D., III, Babbs C. F. Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs. European Journal of Cancer and Clinical Oncology 1982; 18: 1027–1033
   PubMedGoogle Scholar
• Ward-Hartley K. A., Jain R. K. Effect of glucose and galactose on micro-circulatory flow in normal and neoplastic tissues in rabbits. Cancer Research 1987; 47: 317–377
   Google Scholar
• Wike-Hooley J. L., Haveman J., Reinhold H. S. The relevance of tumour pH to the treatment of malignant disease. Radiotherapy Oncology 1984; 2: 343–366
   PubMed Web of Science ®Google Scholar